Atlas Trials

The Effective and Safety of Thalidomide in TI

Clinical trial NCT03184844 · UNKNOWN

Trial details

NCT number
NCT03184844
Sponsor
Xiao-Lin Yin
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Thalassemia
Start date
2017-05-02
Primary completion
2019-02-02
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.